2024年数字健康趋势报告：对研究和患者诊治的影响

IMPLICAT IONS FOR RESE ARCH AND PAT IENT CARE DECEMBER2 0 2 4 Introduction Digital health companies have faced headwinds overthe past few years. Startups have seen reduced fundinginflows while companies with approved products havestruggled to grow revenue and expand their user base.Some have gone bankrupt. However, innovation hasremained strong and new digital health products todiagnose, treat and remotely monitor patients are nowlaunching into a more mature global marketplace withan expanding number of approval and reimbursementpathways that offer improved chances of future success.Developers are also combining individual product typesinto “solutions” with both patient and physician-facinginterfaces that increase the case for health systemadoption. In the research space, biopharma companieshave been using wearable sensors and digital measuresin drug trials to better understand drug benefits andreduce risk. AI-informed digital platforms that are now helpingproviders globally improve outcomes for patients withchronic diseases. For the first time, we also examine theuptake of these solutions in the marketplace drawing onvarious IQVIA data sources. A follow-up to this report, to be released in early 2025,will then look across segments to examine how businessstrategies are shifting in the pursuit of revenue, thepathways digital products are taking to reach the marketand gain reimbursement, and how payer evidencerequirements and government policies are shiftingglobally and may influence adoption. The study was produced independently by theIQVIA Institute for Human Data Science as a publicservice, without industry or government funding.The contributions to this report of Salma Ajraoui,Oliver Bailey, Kate Bennet, Anna Exenberger, MatthewHackenberg, Michael Krupnick, Nadea Leavitt, BrianLovinguth, Christopher Ludwig, Nicholas Mageras, SaraPawley, Maximilian Peters, Covadonga Fernández delPozo, Tapan Raval, Brinda Sriskantha, Erika Szewkies,Ainhoa Uribarren and dozens of others at IQVIA aregratefully acknowledged. This report examines trends across various segmentsof the digital health market, which are becomingincreasingly defined. We examine digital diagnosticsalongside maturing therapeutic product segments likedigital therapeutics (DTx) and digital care (DCs) andlook at consumer apps and non-prescription digitaltherapeutics that aim to reduce health symptoms.We also examine how life sciences companies arestrategically deploying wearable sensors and otherpatient monitoring tools in research. Find Out More If you wish to receive future reports from the IQVIAInstitute for Human Data Science or join our mailing list,visit iqviainstitute.org. While past IQVIA Institute digital health reports havefocused mostly on consumer-facing digital healthtechnologies, this report also explores provider-focusedsolutions, like digital diagnostics, clinical decisionsupport tools, remote patient monitoring tools and MURRAY AITKENExecutive DirectorIQVIA Institute for Human Data Science REFERENCING THIS REPORT Please use this format when referencing content from this report:Source: IQVIA Institute for Human Data Science. Digital Health Trends 2024: Implications for Research and Patient Care. December 2024.Available from www.iqviainstitute.org ©2025 IQVIA and its affiliates. All reproduction rights, quotations, broadcasting, publications reserved. No part of this publication may be reproduced ortransmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, withoutexpress written consent of IQVIA and the IQVIA Institute. Digital Health Trends 2024: Implications for Research and Patient Care Table of Contents Overview2The landscape of digital health6Consumer app trends11Digital therapeutics and their use in care24Sensor-based digital measures44Digital diagnostics and other health assessment tools52Uptake and use of digital health technologies68Notes on sources77Methodology78References80About the authors89About the Institute90 Overview Disease-specific apps continue to grow in number,with many supporting mental health and patientswith diabetes and cardiovascular diseases. Recently-launched apps also help those with visual impairments,auditory issues and dermatologic conditions. Withincreased competition in most categories and continuedcommercial headwinds, new health app entrants facechallenges to grow and differentiate themselves in themarket. Even for high quality apps uptake is relativelyslow. While some notable consumer apps attain 420,000installs on average after five years, disease managementapps see only about 90,000 installs, although newerapps appear to be growing more quickly. Apps withstronger clinical evidence have seen higher rates ofuse and more rapid uptake, indicating that evidencegeneration is now increasingly important for consumeradoption and commercial success. THE LANDSCAPE OF DIGITAL HEALTH While the past two year